Advertisement

Topics

Glucagon Receptor Agonist Shows Early Promise in Type 1 Diabetes

05:45 EDT 19 Jun 2017 | Medscape

Though early days, this proof-of-concept study is 'exciting' research because 'if we could normalize glucagon regulation [in diabetes] this could be a very significant advance,' said one expert.
Medscape Medical News

Original Article: Glucagon Receptor Agonist Shows Early Promise in Type 1 Diabetes

NEXT ARTICLE

More From BioPortfolio on "Glucagon Receptor Agonist Shows Early Promise in Type 1 Diabetes"

Advertisement
Quick Search
Advertisement
Advertisement